Quick Answer
Neuraxis, INC reported R&D Expense of $493.6 thousand for fiscal year 2025.
Neuraxis, INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $493.6K | +13.8% |
| 2024 | $433.6K | +156.1% |
| 2023 | $169.3K | -25.0% |
| 2022 | $225.6K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $130.8K | +3.6% | +124.4% |
| June 30, 2025 | $58.3K | +7.4% | -3.7% |
| March 31, 2025 | $60.6K | +987.2% | -52.0% |
| September 30, 2024 | $126.2K | +180.9% | +132.4% |
| June 30, 2024 | $54.3K | -50.5% | +875.1% |
| March 31, 2024 | $5.6K | -66.8% | -87.6% |
| September 30, 2023 | $45.0K | -47.8% | -59.1% |
| June 30, 2023 | $109.8K | +703.4% | +553.6% |
- Neuraxis, INC showed an increase of +13.8% in R&D Expense compared to the prior fiscal year.
- Over the 2022–2025 period, Neuraxis, INC’s r&d expense has grown by 118.8% (from $225.6 thousand to $493.6 thousand).
- The most recent figure is from Neuraxis, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: